Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE)
This important study, called N-BRAVE, is for people with advanced Hodgkin lymphoma, a type of blood cancer. We are testing two different treatment approaches: one is a standard treatment, and the other is a new combination of medicines that includes a drug called Nivolumab. The main goal is to see which treatment is more effective at making the cancer disappear completely, as measured by special scans called PET/CT. We also want to understand how each treatment affects patients' general health, their quality of life, and if there are any new or different side effects. By comparing these treatments, we hope to find better ways to help people with Hodgkin lymphoma.
At a glance
What is this study about?
This study, known as N-BRAVE, is a significant step in understanding and improving treatments for Hodgkin lymphoma — a type of cancer that affects your body's immune system. We are focusing on patients who have advanced forms of the disease. The study aims to compare two different ways of treating this cancer. One treatment plan is a standard approach that doctors currently use, and the other is a new combination of medicines that we believe could be more effective or have different benefits.
The main thing we want to find out is how well each treatment can make the cancer completely disappear. We will use special scans called PET/CT scans to check this a few weeks after treatment finishes. But we're also interested in many other important things, like how the treatments affect your overall health, your everyday life, and if there are any side effects. We'll also look at things like how quickly you recover and your long-term health.
By carefully comparing these two treatment plans, doctors hope to gain valuable information that can lead to better care for people with Hodgkin lymphoma in the future. The results of this study will help us understand which treatment option might be the best choice for patients, offering the highest chance of getting well and maintaining a good quality of life.
Key takeaways
- This study compares two Hodgkin lymphoma treatments: a standard one and a new combination.
- The main goal is to find out which treatment is better at making the cancer disappear.
- It also looks at how treatments affect your general health and quality of life.
- Participants will have regular check-ups, scans, and blood tests.
- You'll be closely monitored, but there are potential risks and benefits to consider.
- You can stop participating in the study at any time.
Who may be eligible?
This study is looking for adults aged 18 and over, of any gender. You would need to have been diagnosed with advanced Hodgkin lymphoma to be considered for this trial.
There might be other specific health requirements or conditions that would determine if this study is right for you. These will be discussed in detail by the study team and your doctor to ensure your safety and that the study is a good match for your situation.
It's important to have an open conversation with your doctor about all your medical history to see if you meet all the necessary criteria for taking part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with advanced Hodgkin lymphoma?
- Are you able to attend regular hospital or clinic appointments?
- Are you prepared for blood tests and scans?
- Are you willing to discuss your full medical history with the study doctors?
What does participation involve?
If you decide to take part in this study, you will receive one of two treatment plans for your Hodgkin lymphoma. Both plans involve a combination of different medications, which will be given to you over a period of time. You will have regular visits to the clinic or hospital for these treatments and check-ups.
During the study, you will have various assessments to monitor your health and the effectiveness of the treatment. These include blood tests, physical examinations, and special scans like PET/CT scans at specific points, for example, after a few treatment cycles and at the end of your chemotherapy. You'll also be asked to fill out questionnaires about your quality of life.
Follow-up appointments will continue after your active treatment finishes to monitor your long-term health and check for any recurrence of the cancer. The total duration of your participation, including follow-up, will be throughout the study period, which could be several years, depending on the specific schedule for monitoring your progress.
Potential risks and benefits
Locations (1)
- —UnverifiedPoland
Common questions
What is Hodgkin lymphoma?
Hodgkin lymphoma is a type of cancer that starts in white blood cells called lymphocytes, which are part of your body's immune system.
What is a PET/CT scan?
A PET/CT scan is a special imaging test that helps doctors see how active cancer cells are in your body and how well treatments are working.
What does 'advanced' Hodgkin lymphoma mean?
'Advanced' means the cancer is no longer limited to one area and may have spread to other parts of your body. Doctors will explain your specific situation.
Will I know which treatment I'm getting?
In some studies, patients or doctors don't know which treatment is being given (this is called 'blinding') to ensure fair results. The study team will explain how this works for N-BRAVE.
What does 'quality of life' mean in a study?
Quality of life in a study refers to how the treatment affects your overall well-being, including your physical and emotional health, and your daily activities.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.